Peroxiredoxins in Colorectal Cancer: Predictive Biomarkers of Radiation Response and Therapeutic Targets to Increase Radiation Sensitivity?

Colorectal cancer (CRC) is the third most common cancer in the Western world, with one-third of cases located in the rectum. Preoperative radiotherapy is the standard of care for many patients with rectal cancer but has a highly variable response rate. The ability to predict response would be of gre...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Jesse, Eglinton, Tim W., Frizelle, Frank A., Hampton, Mark B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210826/
https://www.ncbi.nlm.nih.gov/pubmed/30301137
http://dx.doi.org/10.3390/antiox7100136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210826/
https://www.ncbi.nlm.nih.gov/pubmed/30301137
http://dx.doi.org/10.3390/antiox7100136

Ejemplares similares